🕵️ Telomir Pharmaceuticals, Inc. ($TELO)
SEC insider & ownership activity, last 12 months · CIK 1971532 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. One red-flag 8-K in the window: Delisting notice (3.01), Jan 8, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| JOHN PAUL DeJoria, AS (trustee) | 5.2% | 13G | Aug 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Sep 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 14, 2026 | filing ↗ |
| Shareholder vote (5.07) | Sep 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 20, 2026 | filing ↗ |
| Other events (8.01) | Apr 24, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 22, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Apr 22, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 22, 2026 | filing ↗ |
| Other events (8.01) | Mar 31, 2026 | filing ↗ |
| Other events (8.01) | Mar 30, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 23, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Mar 23, 2026 | filing ↗ |
| Shareholder vote (5.07) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Other events (8.01) | Feb 17, 2026 | filing ↗ |
| Other events (8.01) | Feb 5, 2026 | filing ↗ |
| Delisting notice (3.01) | Jan 8, 2026 | filing ↗ |
| Other events (8.01) | Jan 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 17, 2025 | filing ↗ |